Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
In July 2023, Roche and AInylam reached an agreement to obtain the cooperative development and commercialization rights of the drug for a total transaction value of up to $2.8 billion
, , 20-30
* After losing weight with another GLP-1 provider, Serena chose Ro to continue her weight loss journey
FLEXIBILITY: Quarter-dosing tablets allow for more flexibility in adjusting the dosage
The D-Phe at position 7 (D-Phe-7 in -MSH numbering) is a well-known potency-enhancing substitution originally identified by Hadley and colleagues in linear -MSH analog studies, the D-stereochemistry produces a constrained backbone conformation that fits the melanocortin receptor binding pocket with enhanced affinity
US$ 29.43
US$ 20.61
US$ 20.75
